MedTrace Logo

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

NCT04278937 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-16

No results posted yet for this study

Summary

In women with indicated vaginal cerclage, this study aims to assess the efficacy of antenatal prophylactic Azithromycin in preventing preterm labor.

Conditions

Interventions

DRUG

Azithromycin Tablets

one tablet orally twice daily for three days in 3 courses at 14 weeks, 24 weeks and 32 weeks

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Sherif A Ashoush, MD · Professor

  • Hassan A Bayoumy, MD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2020-02-15
Completion
2020-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04278937 on ClinicalTrials.gov